SIREN : 452148026
ETS O.P. is a French company founded 22 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in PAU (64000), this company of category PME shows in 2022 a revenue of 1.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2023 | 2022 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Revenue | N/C | 1 615 135 € | N/C | N/C | 1 164 937 € | 1 273 451 € |
| Net income | 281 803 € | 352 842 € | 258 596 € | 196 912 € | 187 292 € | 228 682 € |
| EBITDA | N/C | 515 644 € | N/C | N/C | 251 446 € | 360 648 € |
| Net margin | N/C | 21.8% | N/C | N/C | 16.1% | 18.0% |
In 2023, ETS O.P. generates positive net income of 282 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 229 k€ -> 282 k€.
281 803 €
The debt ratio (= Financial debt / Equity x 100) stands at 7%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 83%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
6.833%
82.877%
39.3%
In 2023, the debt ratio of ETS O.P. (6.83) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2023, the financial autonomy of ETS O.P. (82.9%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2022, the repayment capacity of ETS O.P. (0.04) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 308.26. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
308.258
In 2023, the liquidity ratio of ETS O.P. (308.26) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2022, the interest coverage of ETS O.P. (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 124 transactions of similar company sales (all years), the value of ETS O.P. is estimated at 231 505 € (range 88 112€ - 845 429€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare ETS O.P. with other companies in the same sector:
The revenue of ETS O.P. in 2022 is 1.6 M€.
Yes, ETS O.P. generated a net profit of 282 k€ in 2023.
The headquarters of ETS O.P. is located in PAU (64000), in the department Pyrenees-Atlantiques.
The tax return of ETS O.P. is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
ETS O.P. operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.